Enter and Destroy the Biofilm Matrix: Dispersing Bacterial Biofilms with Engineered, Enzymatically Active Bacteriophage

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		04-61
IP Type:		Licensable Technology
Title:		Enter and Destroy the Biofilm Matrix: Dispersing Bacterial Biofilms with Engineered, Enzymatically Active Bacteriophage
Inventor:		Collins, James J
Summary:		Bacterial biofilms are sources of contamination that are difficult to eliminate in a variety of industrial, environmental and clinical settings. To address this problem, the inventors have engineered enzymatically active bacteriophage that significantly reduce Escherichia coli biofilm by simultaneously degrading the extracellular biofilm matrix, and infecting and lysing biofilm-embedded cells.
Tech Type:		Research Tools \| Therapeutics - Methods \| Therapeutics - Methods
URL:		http://ctf-fmfe.bu.edu/BU0461.pdf
Contact:		Hong Xu, rclark@bu.edu, 617 358 4208
Organization:		Boston University

Display all intellectual properties for Collins, James J
Display all intellectual properties for Boston University